Shanghai Livzon Pharmaceutical

Shanghai Livzon Pharmaceutical is a key subsidiary of the Livzon Pharmaceutical Group, specializing in the research, development, and manufacturing of hormonal and reproductive health medications. The company is a leader in the Chinese market for assisted reproductive technology (ART) drugs, producing essential treatments such as leuprorelin acetate and various gonadotropins. Beyond reproductive health, it maintains a diverse portfolio including digestive, anti-infective, and oncology products. Shanghai Livzon operates high-standard manufacturing facilities that comply with international GMP requirements, supporting both domestic supply and global expansion efforts. The company leverages the extensive R&D and commercial infrastructure of its parent group to maintain a competitive edge in the specialty biopharmaceutical sector.